Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection

被引:264
作者
LeVine, AM [1 ]
Kurak, KE [1 ]
Bruno, MD [1 ]
Stark, JM [1 ]
Whitsett, JA [1 ]
Korfhagen, TR [1 ]
机构
[1] Childrens Hosp, Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA
关键词
D O I
10.1165/ajrcmb.19.4.3254
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To determine the role of surfactant protein-A (SP-A) in host defense, the murine SP-A locus was targeted by homologous recombination to produce mice lacking SP-A. SP-A(-/-) and wild-type mice were infected with mucoid Pseudomonas aeruginosa by intratracheal instillation. Pulmonary bacterial loads were greater in SP-A-/- than in wild-type mice, with increased numbers of mucoid P, aeruginosa in lung homogenates at 6 and 24 h after infection. Pulmonary infiltration with polymorphonuclear leukocytes (PMN) was similar in both groups; however, an earlier influx of PMN into the lung occurred in the SP-A(-/-) mice. The number of bacteria phagocytosed by alveolar macrophages was decreased in the SP-A(-/-) mice at 1 h after infection. Superoxide-radical generation by PMN was similar for the SP-A(-/-) and wild-type mice, but nitrite levels were increased in SP-A(-/-) mice. Concentrations of tumor necrosis factor-alpha, interleukin-6, and macrophage inflammatory protein-2 (proinflammatory cytokines) were greater in bronchoalveolar lavage fluid at 2 h after infection in SP-A(-/-) mice. SP-A plays an important role in the pathogenesis of mucoid P. aeruginosa infection in the lung in vivo by enhancing macrophage phagocytosis and clearance of bacteria, and by modifying the inflammatory response.
引用
收藏
页码:700 / 708
页数:9
相关论文
共 45 条
[1]   Inhibition of the human neutrophil respiratory burst by native and synthetic surfactant [J].
Ahuja, A ;
Oh, N ;
Chao, W ;
Spragg, RG ;
Smith, RM .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1996, 14 (05) :496-503
[2]   DECREASED SURFACTANT PROTEIN-A IN PATIENTS WITH BACTERIAL PNEUMONIA [J].
BAUGHMAN, RP ;
STERNBERG, RI ;
HULL, W ;
BUCHSBAUM, JA ;
WHITSETT, J .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (03) :653-657
[3]  
BERGEM ALM, 1991, PSYCHIAT GENET, V2, P9
[4]   Nitric oxide production by rat alveolar macrophages can be modulated in vitro by surfactant protein A [J].
Blau, H ;
Riklis, S ;
VanIwaarden, JF ;
McCormack, FX ;
Kalina, M .
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1997, 272 (06) :L1198-L1204
[5]  
BODEY GP, 1983, REV INFECT DIS, V5, P279
[6]  
Brewer C, 1996, CHEST, V109, P1019
[7]   BACTEREMIC NOSOCOMIAL PNEUMONIA - ANALYSIS OF 172 EPISODES FROM A SINGLE METROPOLITAN AREA [J].
BRYAN, CS ;
REYNOLDS, KL .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1984, 129 (05) :668-671
[8]   A HUMAN-SERUM MANNOSE-BINDING PROTEIN INHIBITS INVITRO INFECTION BY THE HUMAN IMMUNODEFICIENCY VIRUS [J].
EZEKOWITZ, RAB ;
KUHLMAN, M ;
GROOPMAN, JE ;
BYRN, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :185-196
[9]   Mechanisms of nitric oxide-related antimicrobial activity [J].
Fang, FC .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (12) :2818-2825
[10]   INVIVO AND INVITRO ANTIBACTERIAL ACTIVITY OF CONGLUTININ, A MAMMALIAN PLASMA LECTIN [J].
FRIISCHRISTIANSEN, P ;
THIEL, S ;
SVEHAG, SE ;
DESSAU, R ;
SVENDSEN, P ;
ANDERSEN, O ;
LAURSEN, SB ;
JENSENIUS, JC .
SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1990, 31 (04) :453-460